New Key Statistics Module, Z-Score and F-Score
SZSE:301331 Key Ratios
Market Cap ¥ M | 2,803.80 |
Enterprise Value ¥ M | 2,415.12 |
P/E(ttm) | 42.12 |
PE Ratio without NRI | 41.67 |
Forward PE Ratio | -- |
Price/Book | 2.60 |
Price/Sales | 3.66 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.65 |
Revenue (TTM) ¥ M | 767.00 |
EPS (TTM) ¥ | 0.65 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -17.80 |
y-y EBITDA Growth Rate % | -21.00 |
EV-to-EBIT | 30.19 |
EV-to-EBITDA | 30.19 |
PEG | -- |
Shares Outstanding M | 102.89 |
Net Margin (%) | 8.73 |
Operating Margin % | 9.15 |
Pre-tax Margin (%) | 10.11 |
Quick Ratio | 3.05 |
Current Ratio | 3.63 |
ROA % (ttm) | 4.95 |
ROE % (ttm) | 6.01 |
ROIC % (ttm) | 8.65 |
Dividend Yield % | 2.93 |
Altman Z-Score | 7.66 |
SZSE:301331 Number of Guru Trades
SZSE:301331 Volume of Guru Trades
Gurus Latest Trades with SZSE:301331
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301331 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Enwei Pharmaceutical Co Ltd Insider Transactions
No Available Data